Pharmacological HDAC inhibitors such as trichostatin A or MS-275 were protective against renal fibrosis in a rodent model of UUO [55–57], indicative of an anti-fibrotic effect of HDAC inhibitors via inhibition of HDAC enzyme activity. This evidence concerns the gene HDAC9 and renal fibrosis.